Mutations that impair androgen action
- 31 December 1985
- journal article
- review article
- Published by Elsevier in Trends in Genetics
- Vol. 1, 335-339
- https://doi.org/10.1016/0168-9525(85)90129-5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.Journal of Clinical Investigation, 1984
- A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state.Journal of Clinical Investigation, 1984
- Androgens and the Evolution of Male-Gender Identity among Male Pseudohermaphrodites with 5α-Reductase DeficiencyNew England Journal of Medicine, 1979
- Hereditary Male Pseudohermaphroditism Associated with an Unstable Form of 5α-ReductaseJournal of Clinical Investigation, 1978
- Cytosol Androgen Binding in Submandibular Gland and Kidney of the Normal Mouse and the Mouse with Testicular FeminizationEndocrinology, 1976
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974
- Familial Incomplete Male Pseudohermaphroditism, Type 2New England Journal of Medicine, 1974
- SYNDROME OF ANDROGEN INSENSITIVITY IN MAN: ABSENCE OF 5 α - DIHYDROTESTOSTERONE BINDING PROTEIN IN SKIN FIBROBLASTS.1Journal of Clinical Endocrinology & Metabolism, 1974
- Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminizationJournal of Clinical Investigation, 1972
- X-linked Gene for Testicular Feminization in the MouseNature, 1970